Perceptions Across Ethnicities to Develop an Adapted Intervention for Breathlessness (Paint)

February 13, 2024 updated by: University Hospitals, Leicester

PAINT Breathlessness

An individual's experience of their breathlessness is influenced by multiple factors including their medical condition, psychology, sociological and situational circumstances which will include ethnicity. There is currently a lack of evidence exploring the impact of ethnicity in the experience and presentation of breathlessness.

The non-medical management of breathlessness in respiratory diseases includes pulmonary rehabilitation (PR). PR is a highly evidenced exercise-based intervention to help manage breathlessness, improving health-related quality of life and improving survival. Recent audits in England and Wales showed 89% of patients attending PR were recorded as having a White British ethnicity which is in contrast to national ethnicity demographics. This may be because the cultural acceptability of PR components are not fully considered. Therefore, this study will explore how individuals with cardiorespiratory disease from different ethnicities from the Leicestershire population experience and manage their breathlessness through art workshops, focus groups and interviews. Informed by these results, the study team will work with individuals from under-represented ethnicities and key stakeholders to co-design adaptations of PR that may improve the management of breathlessness in underrepresented ethnicities that do not attend conventional PR programmes.

The study is funded by the Wellcome Trust as part of the Leicestershire Health Inequalities Improvement Programme at the University of Leiceste

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

An individual's experience of their breathlessness is influenced by multiple factors including their medical condition, psychology, sociological and situational circumstances which will include ethnicity. There is currently a lack of evidence exploring the impact of ethnicity in the experience and presentation of breathlessness.

The non-medical management of breathlessness in respiratory diseases includes pulmonary rehabilitation (PR). PR is a highly evidenced exercise-based intervention to help manage breathlessness, improving health-related quality of life and improving survival. Recent audits in England and Wales showed 89% of patients attending PR were recorded as having a White British ethnicity which is in contrast to national ethnicity demographics. This may be because the cultural acceptability of PR components are not fully considered. Therefore, this study will explore how individuals with cardiorespiratory disease from different ethnicities from the Leicestershire population experience and manage their breathlessness through art workshops, focus groups and interviews. Informed by these results, the study team will work with individuals from under-represented ethnicities and key stakeholders to co-design adaptations of PR that may improve the management of breathlessness in underrepresented ethnicities that do not attend conventional PR programmes.

The study is funded by the Wellcome Trust as part of the Leicestershire Health Inequalities Improvement Programme at the University of Leiceste

Study Type

Observational

Enrollment (Estimated)

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

cardiovascular

Description

Inclusion Criteria:

  • Stage 1: Art Workshops, Focus Groups and Semi-Structured Qualitative Interviews Willing and able to provide informed consent for participation in the art workshop, focus group/semi-structured qualitative interview Any individual over 18 years across ethnicities Able to communicate in spoken and written English OR Art workshop and interview: translator for an individuals preferred spoken and written language is available.

Identifies as Grades 2-5 on the Medical Research Council Dyspnoea Scale (MRC). Eligible for PR (e.g., confirmed respiratory condition, functional limitations due to breathlessness).

Stage 2: Experience Based Co-design Willing and able to provide informed consent for participation in the co-design process.

Any individual over 18 years Able to communicate in spoken and written English or a translator for their spoken and written language is available.

Eligible for PR (e.g., confirmed respiratory condition, functional limitations due to breathlessness) and identifies as an ethnicity that the intervention is being adapted for or a family member, friend or carer of an individual with breathlessness that is eligible for PR and identifies as an ethnicity that the intervention is being adapted for OR works for healthcare provider in a service that refers to or delivers PR OR is a charity representative.

Able to attend co-design workshops

Exclusion Criteria:

  • Stage 1: Art Workshop, Focus Groups and Semi-Structured Qualitative Interviews Unable to provide informed consent Any individual under 18 years Art workshop and interview: If no translator available. Focus group only: not able to speak English due to group interaction required. Identifies as Grade 1 on the MRC scale. Not eligible for PR (e.g. any significant comorbidities which limits exercise training ability).

Stage 2: Experience Based Co-design Unable to provide informed consent. Any individual under 18 years If no translator is available. Not eligible for PR or does not identify as an ethnicity that the intervention is being adapted for OR a family member, friend or client is not eligible for PR or does not identify as an ethnicity that the intervention is being adapted for OR does not work for a healthcare provider in a service that refers to or delivers PR OR is not a charity representative.

Unable to attend co-design workshops

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Art Workshops, Focus Groups and Semi-Structured Interviews
Time Frame: 21 months
stage 1
21 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
: Experience Based Co-design The co-development of an intervention for breathlessness for under-represented ethnicities.
Time Frame: 21 months
Stage 2
21 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 12, 2024

Primary Completion (Estimated)

November 30, 2025

Study Completion (Estimated)

November 30, 2025

Study Registration Dates

First Submitted

February 13, 2024

First Submitted That Met QC Criteria

February 13, 2024

First Posted (Estimated)

February 21, 2024

Study Record Updates

Last Update Posted (Estimated)

February 21, 2024

Last Update Submitted That Met QC Criteria

February 13, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 162076
  • 322453 (Other Identifier: HRA)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Subscribe